Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Canaccord Genuity bumps up target price on Harbour Energy

(Sharecast News) - Analysts at Canaccord Genuity nudged up their target price on independent oil and gas company Harbour Energy from 275p to 285p on Friday after the group released "a very strong set" of H1 numbers. Canaccord Genuity said Harbour's H1 results pointed to strong production levels, reduced operating costs, "excellent" free cash flow generation, and an "impressive" reduction in net debt.

The Canadian bank also noted that Harbour announced a $100m share buyback for 2025, in addition to the approximately $455m of dividends guided to, for a total of roughly $550m of shareholder returns for 2025.

"Given the uncertainties some have had over the upside potential of the Harbour/Wintershall DEA combination, we believe the progress made in H1 should put most to rest with the Harbour team proving its operational prowess over multiple jurisdictions," said Canaccord Genuity.

"In our view, the area of most interest is the FCF performance and net debt reduction achieved in the first half. Thanks to better-than-expected production, timely hedging and improved cost management, the free cash has really driven the material reduction in net debt. While we do expect a slight reversion here in H2, this is our first real sign of what the combined businesses can do."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

EU warns Meta to change 'addictive Facebook, Instagram or face fine
(Sharecast News) - Tech giant Meta has been threatened with a fine if it does not change Facebook's and Instagram's "addictive" design, the European Commission said on Friday.
GSK hails 'milestone' drug trial results in China
(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip confirmed on Friday.
Polar Capital Technology Trust reports record annual results
(Sharecast News) - Polar Capital Technology Trust reported record annual results on Friday after artificial intelligence-driven gains helped it more than double its net asset value per share and significantly outperform its benchmark.
St James's Place tumbles as partner firm Sovereign Wealth said to be eyeing exit
(Sharecast News) - Shares in St James's Place tumbled on Friday following a report that one of its largest partner firms, Sovereign Wealth, is the latest set to leave as the wealth manager faces retention challenges.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.